DYGIX | ONAIX | DYGIX / ONAIX | |
Total Expense Ratio | 1.16 | 1.17 | 99% |
Annual Report Gross Expense Ratio | 1.16 | 1.17 | 99% |
Fund Existence | 9 years | 21 years | - |
Gain YTD | 15.568 | 14.054 | 111% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 1000 | 100,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 450M | 887M | 51% |
Annual Yield % from dividends | 1.26 | 1.59 | 79% |
Returns for 1 year | 1.41 | 10.63 | 13% |
Returns for 3 years | 49.22 | 39.20 | 126% |
Returns for 5 years | 30.66 | 6.76 | 454% |
Returns for 10 years | N/A | 17.89 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIB | 64.43 | 0.45 | +0.70% |
ProShares Ultra Nasdaq Biotechnology | |||
FMCE | 27.31 | N/A | N/A |
FM Compounders Equity ETF | |||
PJAN | 45.82 | -0.05 | -0.11% |
Innovator US Equity Power Buff ETF™ Jan | |||
PCCE | 14.36 | -0.04 | -0.26% |
Polen Capital China Growth ETF | |||
USSE | 33.25 | -0.20 | -0.59% |
Segall Bryant & Hamill Select Equity ETF |